Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1972 1
1973 1
1975 2
1976 1
1977 6
1978 7
1979 1
1980 5
1981 9
1982 9
1983 7
1984 11
1985 16
1986 12
1987 9
1988 7
1989 21
1990 15
1991 26
1992 16
1993 12
1994 9
1995 7
1996 9
1997 9
1998 6
1999 10
2000 6
2001 11
2002 7
2003 6
2004 10
2005 7
2006 13
2007 17
2008 17
2009 12
2010 12
2011 18
2012 18
2013 20
2014 25
2015 15
2016 23
2017 18
2018 11
2019 26
2020 13
2021 13
2022 12
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

554 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy.
Simões EAF, Center KJ, Tita ATN, Swanson KA, Radley D, Houghton J, McGrory SB, Gomme E, Anderson M, Roberts JP, Scott DA, Jansen KU, Gruber WC, Dormitzer PR, Gurtman AC. Simões EAF, et al. N Engl J Med. 2022 Apr 28;386(17):1615-1626. doi: 10.1056/NEJMoa2106062. N Engl J Med. 2022. PMID: 35476650 Clinical Trial.
METHODS: In a phase 2b trial, we randomly assigned pregnant women, at 24 through 36 weeks' gestation, to receive either 120 or 240 mug of RSVpreF vaccine (with or without aluminum hydroxide) or placebo. The trial included safety end points and immunogenicity end poi …
METHODS: In a phase 2b trial, we randomly assigned pregnant women, at 24 through 36 weeks' gestation, to receive either 120 or 240 mug of RS …
Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine.
Falsey AR, Walsh EE, Scott DA, Gurtman A, Zareba A, Jansen KU, Gruber WC, Dormitzer PR, Swanson KA, Jiang Q, Gomme E, Cooper D, Schmoele-Thoma B. Falsey AR, et al. J Infect Dis. 2022 Jun 15;225(12):2056-2066. doi: 10.1093/infdis/jiab611. J Infect Dis. 2022. PMID: 34931667 Free PMC article. Clinical Trial.
METHODS: This phase 1/2 study randomized adults 18-85 years old to receive placebo or 60, 120, or 240 g RSVpreF (with or without aluminum hydroxide) alone or concomitantly with seasonal inactivated influenza vaccine (SIIV). ...
METHODS: This phase 1/2 study randomized adults 18-85 years old to receive placebo or 60, 120, or 240 g RSVpreF (with or without aluminum …
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
Al Kaabi N, Zhang Y, Xia S, Yang Y, Al Qahtani MM, Abdulrazzaq N, Al Nusair M, Hassany M, Jawad JS, Abdalla J, Hussein SE, Al Mazrouei SK, Al Karam M, Li X, Yang X, Wang W, Lai B, Chen W, Huang S, Wang Q, Yang T, Liu Y, Ma R, Hussain ZM, Khan T, Saifuddin Fasihuddin M, You W, Xie Z, Zhao Y, Jiang Z, Zhao G, Zhang Y, Mahmoud S, ElTantawy I, Xiao P, Koshy A, Zaher WA, Wang H, Duan K, Pan A, Yang X. Al Kaabi N, et al. JAMA. 2021 Jul 6;326(1):35-45. doi: 10.1001/jama.2021.8565. JAMA. 2021. PMID: 34037666 Free PMC article. Clinical Trial.
INTERVENTIONS: Participants were randomized to receive 1 of 2 inactivated vaccines developed from SARS-CoV-2 WIV04 (5 g/dose; n = 13 459) and HB02 (4 g/dose; n = 13 465) strains or an aluminum hydroxide (alum)-only control (n = 13 458); they received 2 intramuscular …
INTERVENTIONS: Participants were randomized to receive 1 of 2 inactivated vaccines developed from SARS-CoV-2 WIV04 (5 g/dose; n = 13 459) an …
Direct Pulp Capping with Calcium Hydroxide, Mineral Trioxide Aggregate, and Biodentine in Permanent Young Teeth with Caries: A Randomized Clinical Trial.
Brizuela C, Ormeño A, Cabrera C, Cabezas R, Silva CI, Ramírez V, Mercade M. Brizuela C, et al. J Endod. 2017 Nov;43(11):1776-1780. doi: 10.1016/j.joen.2017.06.031. Epub 2017 Sep 14. J Endod. 2017. PMID: 28917577 Clinical Trial.
INTRODUCTION: Direct pulp capping treatment is intended to preserve pulp vitality, to avoid or retard root canal treatment, and, in cases with an open apex, to allow continued root development. Historically, calcium hydroxide (CH) was the gold standard material, but nowada …
INTRODUCTION: Direct pulp capping treatment is intended to preserve pulp vitality, to avoid or retard root canal treatment, and, in cases wi …
Success rate of permanent teeth pulpotomy using bioactive materials: A systematic review and meta-analysis of randomized clinical trials.
Silva EJNL, Pinto KP, Belladonna FG, Ferreira CMA, Versiani MA, De-Deus G. Silva EJNL, et al. Int Endod J. 2023 Sep;56(9):1024-1041. doi: 10.1111/iej.13939. Epub 2023 Jun 12. Int Endod J. 2023. PMID: 37254176 Review.
Currently, pulpotomy treatment for permanent teeth primarily utilizes mineral trioxide aggregate (MTA) as the dressing material, followed by calcium hydroxide. While other calcium-silicate-based cements have been suggested for pulpotomy, there is a limited number of studie …
Currently, pulpotomy treatment for permanent teeth primarily utilizes mineral trioxide aggregate (MTA) as the dressing material, followed by …
Comparative efficacy of materials used in patients undergoing pulpotomy or direct pulp capping in carious teeth: A systematic review and meta-analysis.
Fasoulas A, Keratiotis G, Spineli L, Pandis N, De Bruyne MAA, De Moor RJG, Meire MA. Fasoulas A, et al. Clin Exp Dent Res. 2023 Dec;9(6):1129-1148. doi: 10.1002/cre2.767. Epub 2023 Sep 14. Clin Exp Dent Res. 2023. PMID: 37710421 Free PMC article. Review.
An ad hoc subgroup analysis revealed strong evidence of a higher success of DPC with Mineral Trioxide Aggregate (MTA) compared to calcium hydroxide (CH) (odds ratio [OR] = 3.10, 95% confidence interval [CI]: 1.66-5.79). ...
An ad hoc subgroup analysis revealed strong evidence of a higher success of DPC with Mineral Trioxide Aggregate (MTA) compared to calcium …
Comparative efficacy of medicaments or techniques for pulpotomy of primary molars: a network meta-analysis.
Guo J, Zhang N, Cheng Y. Guo J, et al. Clin Oral Investig. 2023 Jan;27(1):91-104. doi: 10.1007/s00784-022-04830-1. Epub 2022 Dec 29. Clin Oral Investig. 2023. PMID: 36580161 Free PMC article. Review.
OBJECTIVES: We performed this network meta-analysis to determine the comparative efficacy of formocresol (FC), ferric sulfate (FS), sodium hypochlorite (NaOCl), calcium hydroxide (CH), mineral trioxide aggregate (MTA), biodentine, and laser for pulpotomy of molar teeth. .. …
OBJECTIVES: We performed this network meta-analysis to determine the comparative efficacy of formocresol (FC), ferric sulfate (FS), sodium h …
Tranexamic acid for upper gastrointestinal bleeding.
Gluud LL, Klingenberg SL, Langholz E. Gluud LL, et al. Cochrane Database Syst Rev. 2012 Jan 18;1:CD006640. doi: 10.1002/14651858.CD006640.pub2. Cochrane Database Syst Rev. 2012. PMID: 22258969 Updated. Review.
Allergen immunotherapy in allergic rhinitis: current use and future trends.
Klimek L, Pfaar O, Bousquet J, Senti G, Kündig T. Klimek L, et al. Expert Rev Clin Immunol. 2017 Sep;13(9):897-906. doi: 10.1080/1744666X.2017.1333423. Epub 2017 Jun 15. Expert Rev Clin Immunol. 2017. PMID: 28532268 Review.
Expert commentary: Immune-modifying agents like Virus-like particles and CpG-motifs, adjuvants like MPL and aluminum hydroxide are evaluated and found to increase and direct the immunological response toward immunological tolerance. ...
Expert commentary: Immune-modifying agents like Virus-like particles and CpG-motifs, adjuvants like MPL and aluminum hydroxide …
Calcium and acid rebound: a reappraisal.
Hade JE, Spiro HM. Hade JE, et al. J Clin Gastroenterol. 1992 Jul;15(1):37-44. doi: 10.1097/00004836-199207000-00010. J Clin Gastroenterol. 1992. PMID: 1500660 Review.
Another possible mode of action involves antral alkalinization with subsequent gastrin release. Other antacids, notably magnesium hydroxide and aluminum hydroxide, may therefore also cause rebound, but the data in this area are less convincing. ...
Another possible mode of action involves antral alkalinization with subsequent gastrin release. Other antacids, notably magnesium hydroxi …
554 results